An official website of the United States government.
Date posted
Funding Agency
(Funded by the National Institutes of Health)
Researchers have developed a new class of biomaterial for a nanovaccine that boosted immunity in mice with metabolic disorders linked to gut bacteria. Metabolic syndrome is a group of conditions that includes obesity, inflammation, and insulin resistance. Nanovaccines have been found to induce stronger immunity than traditional soluble vaccines in pre-clinical models.
